Alto Neuroscience, Inc. ANRO 深 沪
已收盘 10-31 16:00:00 美东时间
14.19
-0.130
-0.91%
华盛通- 最 高14.70
- 今 开14.31
- 成交量 43.69万股
- 最 低 13.53
- 昨 收 14.32
- 总市值 3.84亿
- 52周最高 15.18
- 市盈率 静 --
- 换手率 1.61%
- 52周最低 1.60
- 委 比 33.33%
- 总股本 2707.21万
- 历史最高 24.00
- 量 比 0.51
- 振 幅 8.17%
- 历史最低 1.60
- 每 手 1
- 风险率 1.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 升至45美元！英特尔获多家机构上调目标价；大摩上调拖拉机供应公司(TSCO)评级至"标配"，目标价升至60美元
今日重点评级关注：HC Wainwright & Co.：维持Alto Neuroscience"买入"评级，目标价从10美元升至50美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从110美元升至117美元
10-27 09:45
美股牛股 | 广船国际技术暴涨155%！芯片重大突破引爆市场；“人造肉”公司BYND大涨超127%
广船国际技术暴涨逾155%！AI芯片性能媲美主流图形处理器；“人造肉”公司BYND大涨超127%，将近11.5亿美元零息可转换债券置换成新的资产组合>>
10-21 14:37
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
10-21 18:13
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Replimune Group (NASDAQ:REPL) shares rose 119.1% to $9.86 during Monda...
10-21 02:39
Alto Neuroscience secures $50M in PIPE financing
Alto Neuroscience (NYSE:ANRO) has announced that it has secured approximately $50 million in gross proceeds through a private investment in public equity (PIPE) financing. The $50 million PIPE involv...
10-20 19:42
Alto Neuroscience Announces $50M Private Placement To Accelerate Development Of ALTO-207 In Treatment Resistant Depression
– Financing led by Perceptive Advisors with participation from new and existing biotech focused investors –– Alto expects to use the proceeds of this financing to accelerate development of ALTO-207 in Treatment Resistant
10-20 19:12
美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元
09-30 14:16
Chardan Capital Initiates Coverage On Alto Neuroscience with Buy Rating, Announces Price Target of $15
Chardan Capital analyst Rudy Li initiates coverage on Alto Neuroscience (NYSE: ANRO) with a Buy rating and announces Price Target of $15.
09-29 19:24
Alto Neuroscience Reports Replication Study Results Validating EEG Biomarkers in Schizophrenia
Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced positive results from an
09-09 19:16
美股大行评级 | 财报前夕，家得宝、劳氏、沃尔玛分别获大行上调目标价！瑞银下调赛富时目标价至260美元
今日重点评级关注：Craig-Hallum：维持Applied Digital"买入"评级，目标价从12美元升至23美元；HC Wainwright & Co.：维持Bitdeer Technologies"买入"评级，目标价从18美元升至19美元
08-19 09:56
